Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: Eur J Cancer. 2012 Aug 23;48(18):10.1016/j.ejca.2012.06.027. doi: 10.1016/j.ejca.2012.06.027

Fig. 1.

Fig. 1

(A) SF1101 PK AUC0–t versus Dose: SF1101 Concentrations for dose cohorts ≥140 mg/m2 achieve higher than targeted exposure levels; (B) SF1101 PK Cmax versus Dose: mean and standard deviation for Cmax versus dose, SF1101 concentrations reach 20–30 μM.